BLUESAIL

Core drive of innovation research and development

Bluesail Medical has established R&D centres in the Germany, Shanghai and Singapore and has built up a 24-hour global research and development system, with over 1000 researchers and technicians and holds more than 600 patents.

600

Global patents

6200K

Benefitting patients worldwide

8000K

Cumulative production of stents

Research and Development trends

2023.05.30 发布新品打破“卡脖子”技术，蓝帆医疗出席中国（威海）医药与医疗器械创新发展大会 MORE
2023.05.26 蓝帆外科RenoVue®一次性使用腔内闭式镜头清洗器完成临床试验 MORE
2023.04.11 蓝帆医疗ALLEGRA Plus经导管主动脉瓣膜系统完成上市前临床全国首例入组 MORE
2023.04.03 蓝帆医疗旗下外周赛道雷帕霉素涂层动静脉瘘球囊扩张导管进入临床试验阶段 MORE